Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?

PLoS ONE(2021)10.1371/journal.pone.0255154Source: DataRank Database

Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome? is a research paper published in PLoS ONE (2021). On theSindex it has a DataRank of 0. It has been cited 56 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access56 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.13)OA: goldTopics (18)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

A. Zimmer ORCID,Claudius Gottschalk,Juergen Grafeneder ORCID,Stephani Schmitz ORCID,Sara Kraker ORCID

Live enrichment

PubMed:34324560 PMC:PMC8321230 OpenAlex:https://openalex.org/W3184437506

national science foundation graduate research fellowship program

Grant: DGE1745303

national library of medicine of the national institutes of health

Grant: T32LM012411

heidelberg university hospital

fonds de recherche du québec-nature et technologies b1x research scholarship

FWCI

2.13

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0255154&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0255154&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0255154

journalhttps://doi.org/10.1371/journal.pone.0255154

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34324560

Fields of Study

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Pharmacological Receptor Mechanisms and Effects

MeSH Terms

COVID-19C-Reactive ProteinCerebrovascular DisordersFibrin Fibrinogen Degradation ProductsHumansL-Lactate DehydrogenaseTroponin I

Keywords

MedicineMeta-analysisConfidence intervalOdds ratioInternal medicinePublication biasCoronavirus disease 2019 (COVID-19)Disease

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (3)

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

N/A

1.6DataRank · unranked

The Lancet(2020)

co-cited

10.1016/s0140-6736(20)30183-5

Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19

Arteriosclerosis Thrombosis and Vascular Biology(2020)

co-cited

10.1161/atvbaha.120.314872

Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality

N/A

0.910DataRank · unranked

Journal of Clinical Investigation(2024)

co-cited

10.1172/jci176640

Can we predict the severe course of COVID-19 - a systematic review and meta-analysis of indicators of clinical outcome?

FAIR Checklist

Authors (15)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)

Related Papers (3)